Protein supplement

Collagen Peptides

Collagen peptides are hydrolyzed collagen; in a crossover study of 6 adults, free hydroxyproline in blood peaked within 100 to 130 minutes of a 10 g dose, and the app lists a half-life of 4 hours.1

Moderate evidence (the app's grade, not a conclusion of the sources)Get the app

Level after one dose

Collagen Peptides after one dose: 50% at ~4 h, 25% at 8 h, 12.5% at 12 h.

Drawn from the half-life in the app's model, ~4 h. The model's figures

The app lists collagen peptides as hydrolyzed bovine or marine collagen, primarily type I and III, in the protein sub-category of supplements. Virgilio and colleagues write that collagen "is one of the few animal proteins that contains hydroxyproline (Hyp)".1 The app grades the evidence for collagen peptides as moderate. The studies cited below have different funders: Gelita AG paid part of the costs of the trial by Zdzieblik and colleagues, the trial by Jendricke and colleagues was in part funded by GELITA GmbH, both used a Gelita AG product, and Rousselot BV funded the absorption study and employed five of its authors.2,3,1 Kim and colleagues report that their skin trial "received no external funding", and the meta-analysis by Pu and colleagues was funded by a hospital grant.4,5

In the crossover study of Virgilio and colleagues, the authors conclude that collagen hydrolysates "are digested and absorbed both as free AAs and peptide-bound forms".1 They report that "Pro-Hyp was the most abundant peptide detected in this study after intake of the different CH sources".1 They add that "Relating these findings to biological activity was beyond the scope of this investigation".1 For skin, Kim and colleagues offer a hypothesis rather than a measured result: "It may be hypothesized that the improvements in skin hydration that occurred in the present study might therefore have resulted from increased production of HA via Pro-Hyp derived from LMWCP".4 They follow it with "this needs to be proved with the further studies in the future".4 The supporting findings they cite come from cells and mice, not from their participants: Pro-Hyp stimulating hyaluronic acid synthesis "in human dermal fibroblasts in vitro", and down-regulated matrix metalloproteinases "in UVB-irradiated mice".4 For muscle, Zdzieblik and colleagues write that "The existence of a specific effect on muscular recruitment cannot be assessed on the basis of the design of the study".2

3

Half-life and pharmacokinetics

Values from the Milligram app's model.

Half-life
~4 h
Bioavailability
90%
Typical dose
10–20 g/day
Route
Oral
Time to peak
~2 h

The second column of the table holds the app's own figures, shown beside what the cited sources report.

Table 3.1Half-life and pharmacokinetics4 rows
ParameterApp's figureReported in the sources
Half-life~4 hNo half-life figure in the cited texts; the absorption study sampled blood at 60, 120, 180, 240 and 360 minutes1
Bioavailability90%No absolute bioavailability figure in the cited texts; in the absorption study 36 to 47% of circulating hydroxyproline stayed peptide-bound, depending on the product1
Time to peak~2 hFree hydroxyproline reached maximum plasma concentrations 6 to 10 times baseline within 100 to 130 minutes of a 10 g dose1
RouteOralOral intake in the absorption study and in the skin trial of Kim and colleagues1,4

Virgilio and colleagues, Frontiers in Nutrition, 2024, tested single 10 g doses of fish, porcine and bovine collagen hydrolysates in a randomized, double-blind crossover study with a 7-day wash-out between study days.1 The app's figure for time to peak is about 2 hours (120 minutes), which sits inside the 100 to 130 minutes the study reports for free hydroxyproline.1 The app's half-life of about 4 hours and its 90% bioavailability have no matching figure in the texts cited here. Kim and colleagues note, as background, that small peptides such as Gly-Pro-Hyp "can be detected in human blood, with peak concentrations observed 1–2 h after intake".4

The chart below uses the app's half-life and time to peak; its once-daily interval is the one Kim and colleagues report for their trial.

Level over 6 weeks

Interval between doses

Level, as a share of the peak after one 100 mg dose

As studied: once daily4.

An illustration from a pharmacokinetic model using a half-life of 4 hours. It is not a measured level or a suggested dose.

4

Human studies

The table lists the human studies cited here, in five columns, with the product, dose and funder stated where the source gives them.

Table 4.1Human studies8 rows
Study and yearDesignPeopleDose and lengthMain result
Proksch and colleagues, Skin Pharmacology and Physiology, 20146Randomized, double-blind, placebo-controlled; the PubMed record states no funder669 women aged 35-55 years62.5 g or 5.0 g once daily for 8 weeks; 23 per group6Skin elasticity higher than placebo in both dose groups; moisture and evaporation differences in a subgroup analysis did not reach statistical significance; no side effects noted6
Kim and colleagues, Nutrients, 20184Randomized, double-blind, placebo-controlled; no external funding; authors at the company Newtree464 women aged 40-60 years who started; 53 completed41000 mg low-molecular-weight collagen peptide once daily for 12 weeks4Skin hydration higher than placebo at 6 and 12 weeks; two of three elasticity parameters higher at 12 weeks (R2 p = 0.025, R5 p = 0.027); placebo hydration also rose from baseline at 12 weeks4
Zdzieblik and colleagues, British Journal of Nutrition, 20152Randomized, double-blind, placebo-controlled (silica); part of the costs paid by Gelita AG253 men aged about 72 years with sarcopenia who completed; 7 dropouts215 g/d collagen peptides with guided resistance training, 3 sessions a week, 12 weeks2Fat-free mass +4.2 kg against +2.9 kg, isokinetic quadriceps strength +16.5 Nm against +7.3 Nm, fat mass -5.4 kg against -3.5 kg (all P<0.05 between groups); both groups improved with training; completers' analysis2
Jendricke and colleagues, Nutrients, 20193Randomized, double-blind, placebo-controlled (silicon dioxide); in part funded by Gelita GmbH377 premenopausal women who completed; 13 dropouts315 g/day collagen peptides with resistance training, 3 days a week, 12 weeks3Higher gain in fat-free mass and hand-grip strength and larger fat loss than placebo, with body composition by bioelectrical impedance; leg strength rose in both groups and the results text states no statistically relevant difference between the groups3
Clark and colleagues, Current Medical Research and Opinion, 20087Randomized, double-blind, placebo-controlled; funder not stated in the PubMed record7147 athletes with activity-related joint pain; 97 evaluable710 g collagen hydrolysate in 25 mL liquid, 24 weeks7Six pain parameters changed more than on placebo, for example walking pain -1.11 against -0.46 (p = 0.007); stronger in 63 with knee arthralgia7
Bongers and colleagues, Applied Physiology, Nutrition, and Metabolism, 20208Randomized, placebo-controlled; Radboud University Medical Center; funder not stated in the PubMed record8167 physically active people with self-reported knee pain, median age 63 years810 g/day collagen peptide for 12 weeks8Knee pain scale fell -1.6 with collagen and -1.9 with placebo (p = 0.42); no difference between groups in KOOS or Lysholm scores or in inflammatory, cartilage and bone markers8
Pu and colleagues, Nutrients, 2023 (meta-analysis)5Systematic review and meta-analysis of randomized trials; funded by a hospital grant526 trials, 1721 patients5Hydrolyzed collagen, doses and durations varied by trial5Pooled effect size 0.63 (95% CI 0.38, 0.88) for skin hydration and 0.72 (95% CI 0.40, 1.03) for elasticity; several biases identified5
de Miranda and colleagues, International Journal of Dermatology, 2021 (meta-analysis)9Systematic review and meta-analysis of randomized, double-blind, controlled trials; funder not stated in the PubMed record919 studies, 1,125 participants aged 20 to 70 years, 95% women9Oral hydrolyzed collagen; the authors single out 90 days9Grouped analysis favorable to collagen against placebo for skin hydration, elasticity and wrinkles9

Deeper analysis: skin hydration and elasticity trials

Kim and colleagues, Nutrients, 2018, randomized women aged 40 to 60 years with crow's-feet photodamage scores of 2 to 6 to placebo or 1000 mg of a low-molecular-weight collagen peptide once daily for 12 weeks.4 Six people withdrew consent before the start, 64 began (33 collagen, 31 placebo), and "Eleven participants dropped out of the study for personal reasons, and 53 completed the study".4 Skin hydration was higher in the collagen group than in the placebo group at 6 weeks and 12 weeks (p = 0.000 and p = 0.003).4 The placebo group had no change from baseline at 6 weeks (p = 0.273) but "hydration was significantly increased at 12 weeks (p = 0.001)", which the authors say "might have been due to the effect of the vehicle material and/or cosmetics supplied by investigators".4 For elasticity, R2 and R5 were higher than placebo at 12 weeks (p = 0.025 and p = 0.027), but only R5 improved from baseline within the collagen group (p = 0.002), and the third parameter was not reported as different.4 The authors report that "No adverse reactions were observed in any of the participants during the course of the study".4 The authors write that "this study was done only for female individuals at the age between 40 to 60 years old" and that "it would be also desirable if the larger number of participants is used".4 The study states "This research received no external funding", and the conflict statement reads that "The authors and the company, Newtree Co., Ltd., declare no conflict of interest to any extent"; the first two authors are listed at Newtree and one author at the company Jellice.4 The test collagen peptide was obtained from Newtree, the company at which the first two authors are listed.4

Proksch and colleagues, Skin Pharmacology and Physiology, 2014, randomized 69 women aged 35 to 55 years to 2.5 g or 5.0 g of collagen hydrolysate or placebo once daily for 8 weeks, with 23 in each group.6 Skin elasticity was the primary interest, and the authors report that it "showed a statistically significant improvement in comparison to placebo" in both dose groups at the end of the study.6 For skin moisture and skin evaporation, a positive influence "could be observed in a subgroup analysis, but data failed to reach a level of statistical significance".6 The authors state that "No side effects were noted throughout the study".6 The PubMed record read for this entry has no funding statement and no limitations section, so neither is reported here. Pu and colleagues left the study out of their meta-analysis because it "did not provide data for the placebo group, making it impossible to compare the results with those of the intervention group".5

Deeper analysis: Pu and colleagues, meta-analysis of skin trials

Pu and colleagues, Nutrients, 2023, pooled 18 studies for skin hydration and 19 for elasticity, using a random-effects model.5 Their pooled effect sizes were 0.63 (95% CI 0.38, 0.88) for hydration and 0.72 (95% CI 0.40, 1.03) for elasticity.5 Among secondary results, the subgroup analysis by duration "revealed that 6 weeks of HC supplementation showed no positive effect on skin elasticity (p = 0.05, Figure 9)", and there were no significant differences by collagen source for elasticity (p = 0.21).5 The risk-of-bias assessment found "bias due to missing outcome data in thirteen studies" and "bias due to deviations from intended intervention in seven studies".5 The authors list as limitations that "the interventions used in the included studies exhibited some heterogeneity" and that "the number of patients included in some studies was less than 40".5 The authors declare no conflict of interest.5

Deeper analysis: Zdzieblik and colleagues, sarcopenic men

Zdzieblik and colleagues, British Journal of Nutrition, 2015, studied men with sarcopenia class I or II who all did a guided 12-week resistance training programme, three sessions a week, and took 15 g/d of collagen peptides or silica as placebo.2 A total of 148 people answered a newspaper advertisement, 60 were allocated (30 per group), and 53 completed (26 collagen, 27 placebo), with a mean age of 72.2 years.2 The primary outcome was the change in fat-free mass, measured by dual-energy X-ray absorptiometry.2 Both groups improved with training, and the authors write that the effect "was significantly more pronounced in subjects receiving collagen peptides": fat-free mass +4.2 (sd 2.31) kg against +2.9 (sd 1.84) kg, isokinetic quadriceps strength +16.5 (sd 12.9) Nm against +7.3 (sd 13.2) Nm, and fat mass -5.4 (sd 3.17) kg against -3.5 (sd 2.16) kg, each with P<0.05.2 Sensory motor control, tested with a one-leg stabilisation test, improved in both groups and was not significantly different between them.2 The seven dropouts were all "related to incompliance with the study design and training protocol", and "No serious adverse events were noted".2 The authors list limitations: "The statistical analysis was a completers’ analysis and not an intention-to-treat analysis", a placebo "that did not deliver any extra calories", and "baseline differences in FM and FFM" between groups that "cannot be ruled out completely" as an influence.2 Part of the costs were paid by Gelita AG, which provided the product; one author (Oesser) is listed at CRI, Collagen Research Institute GmbH, Kiel, and the paper states "There are no conflicts of interest".2 The paper adds that two authors "were involved in the design and execution of the study and performed the statistical analysis".2

Deeper analysis: Jendricke and colleagues, premenopausal women

Jendricke and colleagues, Nutrients, 2019, gave 15 g of collagen peptides (a Gelita AG product) or silicon dioxide placebo daily to premenopausal women doing 12 weeks of resistance training three days a week.3 Seventy-seven women completed; "All 13 dropouts failed to comply with the study design, mainly missing too many training days", and "No dropouts occurred through side effects of the supplemented SCP or placebo".3 Both groups gained fat-free mass and lost fat; the collagen group had a significantly higher gain in fat-free mass and hand-grip strength and a "significantly higher reduction" in fat.3 Leg strength rose in both groups (233.5 N in the placebo group, 250.8 N in the collagen group), and the results section states "No statistically relevant difference was observed between the groups", while the conclusion paragraph at the start of the text describes "a more pronounced increase in leg strength in the treatment group compared to the control group".3 The authors name limitations in the text read: body composition was estimated "by using BIA" rather than dual-energy X-ray absorptiometry, because of radiation hazard rules, and baseline dietary intake differed between the groups for carbohydrates and fats; the main results are from a per protocol analysis.3 The study was in part funded by GELITA GmbH, and the authors "declare no conflict of interest".3

Deeper analysis: joint pain trials of Clark and Bongers

Clark and colleagues, Current Medical Research and Opinion, 2008, at Penn State University, randomized 147 varsity or club athletes with activity-related joint pain to 10 g of collagen hydrolysate in 25 mL of liquid or a xanthan placebo for 24 weeks, and data from 97 could be evaluated.7 Six parameters differed from placebo: physician-assessed pain at rest (-1.37 against -0.90, p = 0.025) and five participant-assessed pain measures, for example walking (-1.11 against -0.46, p = 0.007).7 The authors describe the study as "the first clinical trial of 24-weeks duration to show improvement of joint pain in athletes", and write "Despite the study's size and limitations" and "Future studies are needed to support these findings".7 The PubMed record names no funder, so the sponsor and any author ties to it are not reported here. Bongers and colleagues, Applied Physiology, Nutrition, and Metabolism, 2020, gave 10 g/day of collagen peptide or placebo for 12 weeks to 167 physically active people with self-reported knee pain.8 Pain on the visual analog scale fell by -1.6 with collagen and -1.9 with placebo (p = 0.42), and KOOS and Lysholm scores rose in both groups without a difference between them.8 The authors conclude that "CP supplementation over a 12-week period does not reduce knee pain in healthy, active, middle-aged to elderly individuals", and that collagen peptide "did not impact inflammatory, cartilage, and bone (bio)markers".8 The PubMed record names no funder and no stated limitations, so neither is reported here. The two trials differ in people (athletes with activity-related pain against people aged about 63 with knee pain), and in length (24 against 12 weeks), and both gave 10 g a day, so the records do not settle why their results differ.

Deeper analysis: Virgilio and colleagues, absorption crossover

Virgilio and colleagues, Frontiers in Nutrition, 2024, ran a randomized, double-blind crossover pilot at BioTeSys GmbH, Esslingen, Germany, in 6 healthy non-smoking adults aged 19 to 50 years with a body mass index of 19 to 28 kg/m2.1 Free hydroxyproline rose by an average factor of 7.2 for fish, 9.9 for porcine and 6.2 for both bovine products, and the authors report no significant differences in free hydroxyproline exposure between products.1 Among secondary results, some peptides did differ: "statistically significant differences between CH were observed for some, but not all, pharmacokinetic endpoints", including a higher Hyp-Gly level for fish than for low-molecular-weight bovine hydrolysate (p = 0.0112).1 The authors conclude that "the absorption of fish, porcine and bovine CH is highly comparable".1 They state that "the pilot scale sample size limits the generalization of the observed differences", and that single-dose results may not carry over to long-term supplementation.1 The study was funded by Rousselot BV, five authors were employed by Rousselot BV, two by BioTeSys GmbH and two by Triskelion.1

5

Doses reported in studies and on labels

The app's typical dose is 10 to 20 g/day. The table gives what the cited studies report; no label is cited, for the reason given under regulatory status.

Table 5.1Doses reported in studies and on labels8 rows
SourcePreparation and doseLengthPeople
Proksch 201462.5 g or 5.0 g collagen hydrolysate once daily8 weeks69 women aged 35-55 years
Kim 201841000 mg low-molecular-weight collagen peptide once daily12 weeks64 women aged 40-60 years who started
Clark 2008725 mL liquid containing 10 g collagen hydrolysate24 weeks147 athletes randomized; 97 evaluable
Bongers 2020810 g/day collagen peptide12 weeks167 people with knee pain
Zdzieblik 2015215 g/d collagen peptides after resistance training12 weeks53 men with sarcopenia who completed
Jendricke 2019315 g collagen peptides daily12 weeks77 premenopausal women who completed
Virgilio 20241Single 10 g dose of collagen hydrolysate, crossoverOne day per product, 7-day wash-out6 healthy adults
NCT03357432 (registry entry)1015 g hydrolyzed collagen planned, with vitamin C, before jump-rope exerciseRegistry time frame 4 weeks11 male athletes aged 18 to 50 years (actual enrollment in the entry)

None of the studies in the table used 20 g per day, the top of the app's range.

Proksch and colleagues write "No side effects were noted throughout the study" (69 women, 8 weeks).6 Zdzieblik and colleagues report that "No dropout was related to side-effects" and that "No serious adverse events were noted" in 53 men who completed.2 Jendricke and colleagues report that "No dropouts occurred through side effects of the supplemented SCP or placebo".3 Kim and colleagues write "No adverse reactions were observed in any of the participants during the course of the study".4 The PubMed records of the Clark and Bongers trials do not report adverse events.7,8

The app lists no health markers to monitor for collagen peptides. Zdzieblik and colleagues took blood at the start and end to evaluate safety, and report that "no pathological findings could be observed in the routine blood tests".2 Jendricke and colleagues likewise state "no pathological findings were observed in the routine blood test".3 Kim and colleagues report that blood chemistry, urine and vital-sign parameters "were in normal ranges before and after intake" in both groups.4 The registry entry NCT03357432 lists the primary outcome measure as "PINP levels" and posts no results.10

8

Regulatory and anti-doping status

The saved text of the 2026 WADA Prohibited List does not contain the word collagen.11 A search of DailyMed for "collagen peptides" returned 3 labels, all multi-ingredient products or a cosmetic oil, and no regulator assessment of collagen peptides alone was retrieved.

  • The cited texts give no elimination half-life for collagen peptides, so the app's 4 hours has no matching figure.
  • The cited texts give no absolute bioavailability for collagen peptides, so the app's 90% has no matching figure.
  • The app's note that muscle effects are weaker than whey is not tested in any cited trial; Zdzieblik and Jendricke compared collagen with a silica placebo, not with whey.
  • The absorption study had 6 participants and one dose, and its authors say that long-term supplementation may change the blood profile.1
  • The two joint trials point in different directions (Clark, benefit on six pain parameters; Bongers, no difference from placebo), and the cited records do not explain the difference.7,8
What is the half-life of collagen peptides?

The app lists a half-life of about 4 hours for collagen peptides, and none of the cited texts reports an elimination half-life.

How long do collagen peptides take to peak in blood?

The app lists about 2 hours, and Virgilio and colleagues report free hydroxyproline peaking within 100 to 130 minutes.1

Is collagen peptides banned by WADA?

The saved text of the 2026 WADA Prohibited List does not contain the word collagen.11

What are collagen peptides made of?

The app lists hydrolyzed bovine or marine collagen, primarily type I and III, providing glycine, proline and hydroxyproline. Virgilio and colleagues compared fish, porcine and bovine hydrolysates and call their absorption "highly comparable" in 6 adults.1

Did collagen peptides improve skin in trials?

A 2023 meta-analysis of 26 randomized trials (1721 patients) reported pooled effect sizes of 0.63 for skin hydration and 0.72 for elasticity against placebo.5 The same authors identified biases in the included trials, and in the trial of Kim and colleagues the placebo group's hydration also rose from baseline at 12 weeks.5,4

Did collagen peptides reduce joint or knee pain in trials?

Results differ: Clark and colleagues reported lower pain on six parameters than placebo in athletes, while Bongers and colleagues found a similar pain decrease with collagen and placebo (p = 0.42).7,8

Did collagen peptides increase muscle mass in trials?

In 53 men with sarcopenia who completed 12 weeks of resistance training (7 dropouts, completers' analysis), fat-free mass rose by 4.2 kg with 15 g/d collagen peptides and by 2.9 kg with silica placebo, and Gelita AG paid part of the costs.2

What side effects have been reported for collagen peptides?

Four trials report no side effects, adverse reactions, serious adverse events or dropouts from side effects, for example "No adverse reactions were observed in any of the participants during the course of the study" (Kim and colleagues, 64 women started, 53 completed); Zdzieblik and colleagues write "No serious adverse events were noted" and Jendricke and colleagues "No dropouts occurred through side effects of the supplemented SCP or placebo".4,2,3

12

References

  1. Virgilio N, et al. Absorption of bioactive peptides following collagen hydrolysate intake: a randomized, double-blind crossover study in healthy individuals. Front Nutr 2024. PMID 39149544
  2. Zdzieblik D, et al. Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial. Br J Nutr 2015. PMID 26353786
  3. Jendricke P, et al. Specific Collagen Peptides in Combination with Resistance Training Improve Body Composition and Regional Muscle Strength in Premenopausal Women: A Randomized Controlled Trial. Nutrients 2019. PMID 31010031
  4. Kim DU, et al. Oral Intake of Low-Molecular-Weight Collagen Peptide Improves Hydration, Elasticity, and Wrinkling in Human Skin: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients 2018. PMID 29949889
  5. Pu SY, et al. Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients 2023. PMID 37432180
  6. Proksch E, et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol 2014. PMID 23949208
  7. Clark KL, et al. 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin 2008. PMID 18416885
  8. Bongers CCWG, et al. Effectiveness of collagen supplementation on pain scores in healthy individuals with self-reported knee pain: a randomized controlled trial. Appl Physiol Nutr Metab 2020. PMID 31990581
  9. de Miranda RB, et al. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol 2021. PMID 33742704
  10. University of California, Davis. Gelatin, Collagen, Gummy and PINP. ClinicalTrials.gov NCT03357432. NCT03357432
  11. World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2026. WADA list